A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

The Food and Drug Administration recently expanded approval for Spravato, an antidepressant nasal spray used to treat ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

The use of ketamine to treat severe depression was approved in Singapore in October 2020, to be administered as a nasal spray together with oral anti-depressant therapy. Clinical trials have shown ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Legal Disclaimer: ...

If your ability to connect with others feels a little rusty post-pandemic, adding “social fitness” to your workout routine ...

Trusted resource of information on Anxiety & Depression that includes articles, news, videos, animations, quizzes, ...

Jan. 30, 2025 — Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood ...